This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Smith, S. H. Articles by McManus, P. M. Search for Related Content PubMed PubMed Citation Articles by Smith, S. H. Articles by McManus, P. M.

A Comparative Review of Melanocytic Neoplasms

Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA

Melanoma is a devastating disease frequently encountered within both veterinary and human medicine. Molecular changes linked with neoplastic transformation of melanocytes include mutations in genes that encode proteins intrinsic to the regulatory pathways of two tumor suppressor proteins (retinoblastoma protein and p53), proto-oncogene mutation to oncogenes, altered expression of epithelial cadherin and CD44 adhesion molecules, and upregulation of angiogenic factors and other growth factors. Histologic evaluation of the primary mass is the most common means of diagnosis, with cytology used more frequently to document metastasis. Melanoma's highly variable histologic and cytologic patterns can make diagnosis by either method problematic. Adherent epithelioid morphology, including signet ring forms, and nonadherent round and spindle forms are recognized, with pigmentation an inconsistent finding. The site of the tumor, the thickness of the primary tumor or depth of invasion, and the number of mitotic figures per high-power field or per millimeter are used histologically to predict biologic behavior, whereas site and degree of pleomorphism are typically used for cytologic preparations. Diagnosis of amelanotic melanoma can be aided by ancillary diagnostic techniques. Tumor cells are usually positive for vimentin, S100, neuron-specific enolase, and Melan-A, and negative for cytokeratin. Melan-A as a positive marker is not as sensitive as the others are but is likely more specific. Monoclonal antibodies to human melanosome–specific antigens 1 and 5 cross-react with canine antigens for a combined sensitivity rate of 83%. Mouse monoclonal antibody IBF9 specifically recognizes canine melanoma antigen and also has good sensitivity. Serologic markers, including cytokines, cell adhesion molecules, and melanoma-inhibitory activity, are being investigated as potential sentinels of melanoma. Currently, there is no single diagnostic technique capable of differentiating benign from malignant melanocytic neoplasms or predicting survival time.

Key words: Animal; cytology; melanoma; mouth neoplasms; pathology; review; skin neoplasms.

Request reprints from Dr. P. M. McManus, Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, 3800 Spruce Street, Philadelphia, PA 19104 (USA). E-mail: pmcmanus{at}vet.upenn.edu.

This article has been cited by other articles:

				T. Kurotaki, Y. Tomonari, T. Kanno, Y. Wako, and M. Tsuchitani A Novel Immunohistochemical Marker of Normal and Neoplastic Melanocytes in Formalin-fixed, Paraffin-embedded Tissues of Albino Rats Vet. Pathol., May 1, 2008; 45(3): 383 - 387. [Abstract] [Full Text] [PDF]

				V. Mavangira, J. M. Hughes, J. R. Middleton, W. J. Mitchell, and D. Y. Kim Malignant melanoma of the horn base in a Pygora goat J Vet Diagn Invest, January 1, 2008; 20(1): 104 - 107. [Abstract] [Full Text] [PDF]

				J. R. Latendresse, L. Muskhelishvili, A. Warbritton, and W. H. Tolleson Two Cases of Uveal Amelanotic Melanoma in Transgenic Tyr-HRAS+ Ink4a/Arf Heterozygous Mice Toxicol Pathol, October 1, 2007; 35(6): 825 - 830. [Abstract] [Full Text] [PDF]

				W. von Bomhard, M. H. Goldschmidt, F. S. Shofer, L. Perl, K. L. Rosenthal, and E. A. Mauldin Cutaneous Neoplasms in Pet Rabbits: A Retrospective Study Vet. Pathol., September 1, 2007; 44(5): 579 - 588. [Abstract] [Full Text] [PDF]

				G. Avallone, P. Helmbold, M. Caniatti, D. Stefanello, R. C. Nayak, and P. Roccabianca The Spectrum of Canine Cutaneous Perivascular Wall Tumors: Morphologic, Phenotypic and Clinical Characterization Vet. Pathol., September 1, 2007; 44(5): 607 - 620. [Abstract] [Full Text] [PDF]

				J. Sanchez, G. A. Ramirez, A. J. Buendia, M. Vilafranca, C. M. Martinez, J. Altimira, and J. A. Navarro Immunohistochemical Characterization and Evaluation of Prognostic Factors in Canine Oral Melanomas with Osteocartilaginous Differentiation Vet. Pathol., September 1, 2007; 44(5): 676 - 682. [Abstract] [Full Text] [PDF]

				Y. Shimoyama, Y. Akihara, D. Kirat, H. Iwano, K. Hirayama, Y. Kagawa, T. Ohmachi, K. Matsuda, M. Okamoto, T. Kadosawa, et al. Expression of Monocarboxylate Transporter 1 in Oral and Ocular Canine Melanocytic Tumors Vet. Pathol., July 1, 2007; 44(4): 449 - 457. [Abstract] [Full Text] [PDF]

				W. L. Spangler and P. H. Kass The histologic and epidemiologic bases for prognostic considerations in canine melanocytic neoplasia. Vet. Pathol., February 1, 2006; 43(2): 136 - 149. [Abstract] [Full Text] [PDF]

				M. R. Zielinski, M. Muenchow, M. A. Wallig, P. L. Horn, and J. A. Woods Exercise delays allogeneic tumor growth and reduces intratumoral inflammation and vascularization J Appl Physiol, June 1, 2004; 96(6): 2249 - 2256. [Abstract] [Full Text] [PDF]